1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Overview
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analysis
4. Market Dynamics
4.1 Drivers
4.1.1 Ease of Drug Delivery
4.1.2 High Prevalence of Skin Diseases
4.2 Restraints
4.2.1 High Frequency of Product Recalls
4.2.2 Stringent Approval Process
4.3 Opportunities
4.3.1 Power of Suppliers
4.3.2 Power of Consumers
4.4 Challenges
4.4.1 Providing Suitable Medicine
5. Asia-Pacific Topical Drug Delivery Market - By Product
5.1 Formulation
5.1.1 Liquid
5.1.1.1 Solution
5.1.1.2 Suspension
5.1.2 Semi-Solid
5.1.2.1 Ointment
5.1.2.2 Gel
5.1.2.3 Paste
5.1.2.4 Cream & Lotion
5.1.3 Solid
5.1.3.1 Powder
5.2 Device
5.2.1 Patch
5.2.2 Inhaler
5.2.3 Transdermal Drug Delivery
6. Asia-Pacific Topical Drug Delivery Market - By Administration
6.1 Vaginal
6.2 Oral topical
6.3 Ophthalmic
6.4 Nasal
6.5 Dermal
6.6 Skin
6.7 Others
7. Asia-Pacific Topical Drug Delivery Market - By Facility of Use
7.1 Hospitals
7.2 Private Clinics
7.3 Home Care Settings
7.4 Others
8. Asia-Pacific Topical Drug Delivery Market – By Country
8.1 Introduction
8.2 Asia-Pacific
8.2.1 China
8.2.2 India
8.2.3 Japan
8.2.4 Rest of Asia-Pacific
9. Asia-Pacific Topical Drug Delivery Market – By Company Profiles
9.1 Glaxosmithkline
9.2 Galderma
9.3 Valeant Pharmaceuticals
9.4 Hisamitsu Pharmaceuticals
9.5 Novartis
9.6 Johnson & Johnson Services., INC
9.7 Pfizer
9.8 Becton, Dickinson and Company
9.9 Merck & Co., INC
9.10 Huffmann-La roche., LTD
9.11 CPHL
9.12 Ocular Drug Delivery
9.13 Oak Wood Labs
9.14 Labvantage Solutions
9.15 Mylan Pharmaceutical Company
10. Asia-Pacific Topical Drug Delivery Market – By Competitive Landscape
10.1. Market Share Analysis
10.2. Strategies Adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
11. Market Insights
11.1 Insights of Industry Experts
11.2 Analyst Opinion (Market Understanding)
11.3 Investment Opportunities
12. Appendix
12.1 List of Tables
12.2 List of Figures
